Wells Fargo’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-52
Closed -$1.49K 7542
2026
Q1
$1.49K Buy
+52
New +$1.51K ﹤0.01% 6286
2020
Q1
Sell
-237,800
Closed -$5.05M 6686
2019
Q4
$5.05M Sell
237,800
-11,900
-5% -$244K ﹤0.01% 2558
2019
Q3
$4.97M Buy
+249,700
New +$4.97M ﹤0.01% 2554

Other funds holding REVS

Wells Fargo's REVS Position: Q2 2026 in Review

Wells Fargo sold out of Columbia Research Enhanced Value ETF (REVS) in Q2 2026, closing a stake of 52 shares — an estimated $1.49K sold.

Wells Fargo first reported a position in REVS in Q3 2019 and held it in 3 quarters. The position peaked at $5.05M in Q4 2019. 38 funds tracked by Wall St. Rank hold REVS as of Q2 2026.

  • Wells Fargo reported no remaining Columbia Research Enhanced Value ETF position as of Q2 2026 after selling out during the quarter.
  • Wells Fargo sold 52 Columbia Research Enhanced Value ETF shares in Q2 2026, an estimated $1.49K.
  • Wells Fargo first reported a position in Columbia Research Enhanced Value ETF in Q3 2019 and held it in 3 quarters.
  • Wells Fargo's Columbia Research Enhanced Value ETF position peaked at $5.05M in Q4 2019.
  • 38 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.